A convergent strategy for the modification of peptide nucleic acids: Novel mismatch-specific PNA-hybridization probes

Angewandte Chemie - International Edition

Volumn 38, Issue 15, 1999, Pages 2203-2206

  Seitz, Oliver ^a   Bergmann, Frank ^b   Heindl, Dieter ^b  

^a UNIVERSITY OF KARLSRUHE   (Germany)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Fluorescent sensors; Nucleotides; Peptide nucleic acids; Protecting groups; Solid phase synthesis

Indexed keywords

PEPTIDE NUCLEIC ACID;

ARTICLE; CHEMICAL MODIFICATION; CONJUGATION; HYBRIDIZATION; PEPTIDE SYNTHESIS;

EID: 0033516881     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-3773(19990802)38:15<2203::AID-ANIE2203>3.0.CO;2-2     Document Type: Article

References (26)

1. a) E. Uhlmann, A. Peymann, Chem. Rev. 1990, 90, 543;
2. b) J. F. Milligan, M. D. Matteucci, J. C. Martin, J. Med. Chem. 1993, 36, 1923;
3. c) J. Wolff, Gene Therapeutics, Birkhäuser, Boston, MA, 1994;
4. d) A. De Mesmaeker, R. Häner, P. Martin, H. E. Moser, Acc. Chem. Res. 1995, 28, 336.
5. a) B. Hyrup, P. E. Nielsen, Biorg. Med. Chem. 1996, 4, 5;
6. b) P. E. Nielsen, G. Haaima, Chem. Soc. Rev. 1997, 26, 73;
7. c) P. E. Nielsen, Chem. Eur. J. 1997, 3, 505;
8. d) E. Uhlmann, A. Peyman, G. Breipohl, D. W. Will, Angew. Chem. 1998, 110, 2954; Angew. Chem. Int. Ed. 1998, 37, 2796.
9. d) E. Uhlmann, A. Peyman, G. Breipohl, D. W. Will, Angew. Chem. 1998, 110, 2954; Angew. Chem. Int. Ed. 1998, 37, 2796.
10. Introduction of 2-aminopurine: B. P. Gangamani, V. A. Kumar, K. N. Ganesh, Chem. Commun. 1997, 1913; introduction of an anthraquinone: B. Armitage, D. Ly, T. Koch, H. Frydenlund, H. Ørum, H. G. Batz, G. B. Schuster, Proc. Natl. Acad. Sci USA 1997, 94, 12320; see also reference [2d].
11. Introduction of 2-aminopurine: B. P. Gangamani, V. A. Kumar, K. N. Ganesh, Chem. Commun. 1997, 1913; introduction of an anthraquinone: B. Armitage, D. Ly, T. Koch, H. Frydenlund, H. Ørum, H. G. Batz, G. B. Schuster, Proc. Natl. Acad. Sci USA 1997, 94, 12320; see also reference [2d].
12. For a general "submonomer strategy", see L. S. Richter, R. N. Zuckermann, Bioorg. Med. Chem. Lett. 1995, 5, 1159.
13. D. Muller, I. Zeltser, G. Bitan, C. Gilon, J. Org. Chem, 1997, 62, 411.
14. a) O. Seitz, H. Kunz, Angew. Chem. 1995, 107, 901; Angew. Chem. Int. Ed. Engl. 1995, 34, 807;
15. a) O. Seitz, H. Kunz, Angew. Chem. 1995, 107, 901; Angew. Chem. Int. Ed. Engl. 1995, 34, 807;
16. b) O. Seitz, H. Kunz, J. Org. Chem. 1997, 62, 813.
17. K. L. Dueholm, M. Egholm, C. Behrens, L. Christensen, H. F. Hansen, T. Vulpius, K. H. Petersen, R. H. Berg, P. E. Nielsen, O. Buchardt, J. Org. Chem. 1994, 59, 5767.
18. Very recently, an alternative solid-phase synthesis of PNA monomers has been published. However, this strategy would not be compatible with Fmoc-and acyl-type protecting groups : G. Aldrian-Herrada, A. Rabié, R. Wintersteiger, J. Brugidou, J. Pept. Sci. 1998, 4, 266.
19. C. R. Allerson, S. L. Chen, G. L. Verdine, J. Am. Chem. Soc. 1997, 119, 7423.
20. The synthesis of 9 will be reported elsewhere.
21. T. Koch, H. F. Hansen, P. Andersen, T. Larsen, H. G. Batz, K. Otteson, H. Ørum, J. Pept. Res. 1997, 49, 80.
22. 11: MS (MALDI-TOF, 2,5-dihydroxybenzoic acid (DHB), positive ion): 3091 (calcd: 3090).
23. Changes of the fluorescence resonance energy transfer between two fluorescent dyes can be monitored in the presence or in the absence of a complementary DNA strand. For a similiar experiment using labeled oligonucleotide probes, see N. Ota, K. Hirano, M. Warashina, A. Andrus, B. Mullah, K. Hatanaka, K. Taira, Nucleic Acids Symp. Ser. 1997, 37, 207.
24. L. G. Lee, C.-H. Chen, L. A. Chiu, Cytometry 1986, 7, 508.
25. max = 257, 500 nm.
26. A. N. Glazer, H. S. Rye, Nature 1992, 359, 859.